Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Anavex Life Sciences Corp. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 108 | 127 | +19 |
| Shares | 18.2M | 21.6M | +3.39M (+18.6%) |
| Value | $271.9M | $492.2M | +$220.4M (+81.1%) |
New holders (36)
Institutions that held Anavex Life Sciences Corp. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (17)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 179,185 | $2.68M |
| Marshall Wace, LLP | 163,087 | $2.44M |
| California Public Employees Retirement System | 106,800 | $1.60M |
| ExodusPoint Capital Management, LP | 25,007 | $374.0K |
| Bank of Montreal | 23,692 | $358.0K |
| Creative Planning | 17,750 | $265.0K |
| Stratos Wealth Partners, LTD. | 11,100 | $166.0K |
| SG Americas Securities, LLC | 10,419 | $156.0K |
| Tatro Capital, LLC | 10,000 | $150.0K |
| Harbour Investments, Inc. | 3,000 | $45.0K |
| Pacer Advisors, Inc. | 2,786 | $42.0K |
| Optimum Investment Advisors | 2,000 | $30.0K |
| Atlas Private Wealth Management | 1,746 | $26.0K |
| Point72 Hong Kong Ltd | 1,350 | $20.0K |
| RMR Wealth Builders | 250 | $4.00K |
| Sowell Financial Services LLC | 20 | $0 |
| Banco Bilbao Vizcaya Argentaria, S.A. | 10,880 | – |